Claim-to-evidence explorer

Start with a reviewed podcast moment. Ask a precise question, then inspect related research and its limits.

6 reviewed excerpts

This is the reviewed portion of our larger video index. Related studies provide context; they do not automatically verify a speaker’s claim. Unprocessed videos are not included as reviewed claims.

Search reviewed discussionsPeptide

Video thumbnail for BURN FAT FASTER WITH MOTS C | Josh Holyfield | Real Bodybuilding Podcast

▶ Watch at 14:11

Fouad Abiad Media · Publication date not recorded

Separating perceived peptide effects from changed habits

Research context linked · Claim not verified

The speakers name several peptides while discussing how changes in nutrition, sleep, and training can accompany perceived benefits. This is a discussion of experience and confounding factors, not a controlled comparison.

Question to take to the evidence

Did a study isolate the peptide’s effect from simultaneous changes in behavior?

Reviewed excerpt: 851–940 seconds · 2026-10-04. Caption excerpt reviewed · Claims not independently verified. Summary is a paraphrase; no full-video review implied.

Compare with selected research

These are related studies from our library, not confirmed sources cited by the speaker. Their populations and outcomes may differ from the claim.

BPC-157

A tendon-cell experiment cannot establish recovery time, pain relief, or a reliable injury treatment in people.

Growth-hormone receptor experiment · Rat tendon-cell study (2014) →

Achilles tendon transection model · Animal + cell study (2003) →

Medial collateral ligament healing · Animal study (2010) →

BPC-157 · two-person safety pilot · Uncontrolled human pilot (2025) →

Elamipretide

Forzinity has a specific Barth syndrome indication; this is not approval for general longevity use.

TAZPOWER · Human crossover trial + open extension (2021) →

SS-31 · inflammatory memory model · Animal study (2019) →

TB-500

FDA identifies a thymosin beta-4 fragment under this name. Findings about full-length thymosin beta-4 do not automatically transfer.

Thymosin beta-4 active regions · Related-peptide mechanistic review (2010) →

RGN-259 in severe dry eye — related molecule · Related-compound human trial (2015) →

BPC-157 · Elamipretide · TB-500

▶ Watch at 43:11

Fouad Abiad Media · Publication date not recorded

Skin claims reaching a wider audience

Research context linked · Claim not verified

The host describes hearing skin-related GHK-Cu claims from people outside bodybuilding. The passage illustrates the spread of a claim; it does not provide clinical evidence that the claim is true.

Question to take to the evidence

Does the cited skin study use the same formulation and route as the product being discussed?

Reviewed excerpt: 2591–2647 seconds · 2026-10-04. Caption excerpt reviewed · Claims not independently verified. Summary is a paraphrase; no full-video review implied.

Compare with selected research

These are related studies from our library, not confirmed sources cited by the speaker. Their populations and outcomes may differ from the claim.

GHK-Cu

Topical products, injected preparations, and animal studies answer different questions.

Irradiated wound model · Animal / laboratory study (2013) →

Connective-tissue accumulation in wound chambers · Animal study (1993) →

GHK-Cu

Video thumbnail for PEPTIDES FOR ANXIETY? |SEMAX & SELANK | Real Bodybuilding Podcast

▶ Watch at 1:59

Fouad Abiad Media · Publication date not recorded

Personal reports of focus and mood

Research context linked · Claim not verified

The host reports perceived improvements in focus and mood and asks the guest for an explanation. The guest acknowledges that research populations differ from healthy people seeking optimization.

Question to take to the evidence

Is the proposed benefit supported by trials in the same population, rather than a personal account?

Reviewed excerpt: 119–183 seconds · 2026-10-04. Caption excerpt reviewed · Claims not independently verified. Summary is a paraphrase; no full-video review implied.

Compare with selected research

These are related studies from our library, not confirmed sources cited by the speaker. Their populations and outcomes may differ from the claim.

Semax

Animal brain findings do not demonstrate improved focus or mood in otherwise healthy people.

Ischemia transcriptome study · Rat brain experiment (2014) →

Semax · early clinical stroke report · Human comparative study (1997) →

Semax

▶ Watch at 13:35

Fouad Abiad Media · Publication date not recorded

Proposed neurochemical explanations

Research context linked · Claim not verified

The conversation links these neuropeptides to the host’s experience, then proposes neurotransmitter and growth-factor explanations for Semax. These mechanistic claims need separate study-level verification.

Question to take to the evidence

Are the proposed mechanism and meaningful clinical outcome both demonstrated in humans?

Reviewed excerpt: 815–878 seconds · 2026-10-04. Caption excerpt reviewed · Claims not independently verified. Summary is a paraphrase; no full-video review implied.

Compare with selected research

These are related studies from our library, not confirmed sources cited by the speaker. Their populations and outcomes may differ from the claim.

Selank

A small comparative study is not a complete evidence base for routine anxiety treatment.

Anxiety-disorder comparison · Small human comparative study (2014) →

Selank versus medazepam · 2008 · Human active-comparator study (2008) →

Semax

Animal brain findings do not demonstrate improved focus or mood in otherwise healthy people.

Ischemia transcriptome study · Rat brain experiment (2014) →

Semax · early clinical stroke report · Human comparative study (1997) →

Selank · Semax

Video thumbnail for RETATRUTIDE: EVERYTHING YOU NEED TO KNOW | Wes Christensen | Fouad Abiad's Real Bodybuilding Podcast

▶ Watch at 10:38

Fouad Abiad Media · Publication date not recorded

Comparing metabolic peptides in conversation

Research context linked · Claim not verified

The speakers compare personal experiences and describe differences among semaglutide, tirzepatide, and retatrutide. Their tolerability anecdotes are not a head-to-head clinical trial.

Question to take to the evidence

Does a comparative trial support the claimed difference in effectiveness or adverse effects?

Reviewed excerpt: 638–726 seconds · 2026-10-04. Caption excerpt reviewed · Claims not independently verified. Summary is a paraphrase; no full-video review implied.

Compare with selected research

These are related studies from our library, not confirmed sources cited by the speaker. Their populations and outcomes may differ from the claim.

Retatrutide

“R”, “Reta”, and “GLP-3” are candidate seller shorthand, not verified product identities.

Triple-receptor obesity trial · Human phase 2 trial (2023) →

Phase 2 trial in type 2 diabetes · Human randomized trial (2023) →

TRIUMPH-1 phase 3 obesity trial · Human phase 3 randomized trial (2026) →

TRIUMPH-2 phase 3 trial in type 2 diabetes · Human phase 3 randomized trial (2026) →

Semaglutide

Brand, formulation, and indication matter. An approved product does not validate a research-use-only version.

STEP 1 · Human randomized trial (2021) →

SELECT cardiovascular outcomes · Human randomized trial (2023) →

STEP 4 · continuation versus withdrawal · Human randomized withdrawal trial (2021) →

Tirzepatide

Mounjaro, Zepbound, compounded preparations, and research products have distinct identities.

SURMOUNT-1 · Human randomized trial (2022) →

SURPASS-2 direct comparison in type 2 diabetes · Human randomized trial (2021) →

SURMOUNT-4 · continuation versus withdrawal · Human randomized withdrawal trial (2024) →

Retatrutide · Semaglutide · Tirzepatide

Video thumbnail for The Best Peptide to Truly Lose Fat is Not GLP-1, it’s MOTS-C to Boost Mitochondria

▶ Watch at 19:03

Thomas DeLauer · Publication date not recorded

Myostatin and a proposed muscle pathway

Exact study link unresolved

The discussion refers to a rodent study while connecting MOTS-c, mitochondria, and myostatin. The exact study behind the numerical claim has not been verified for this note.

Question to take to the evidence

Which primary paper supports the claim, and were the outcomes measured in rodents or people?

Reviewed excerpt: 1143–1220 seconds · 2026-10-04. Caption excerpt reviewed · Claims not independently verified. Summary is a paraphrase; no full-video review implied.

Compare with selected research

These are related studies from our library, not confirmed sources cited by the speaker. Their populations and outcomes may differ from the claim.

MOTS-c

Experiments in cells and mice do not establish exercise replacement or weight-loss outcomes in people.

Metabolic homeostasis study · Animal / laboratory study (2015) →

Exercise-associated signaling and mouse physical performance · Human observations + mouse experiments (2021) →

The numerical claim’s exact primary source has not been identified. No verification verdict is assigned.

MOTS-c

PepsRadar editorial summaries · Not reviewed by a medical professional · Selected coverage, not a systematic review. Source-check dates do not mean continuous monitoring.